Cellenkos Inc., a privately held, clinical-stage biotechnology company, has selected Cryoport to provide a staged, on-demand, logistics solution for Covid-19 therapy shipments for patients in need.   Working in concert, Cryoport Systems, CRYOPDP and CRYOGENE will provide the highest possible available level of tracking and proactive management for the therapies, including continuous monitoring of each step from scheduling, collection, confirming courier pickups/deliveries, and monitoring transpo...